CTOR Latest Press Releases

-- November 11, 2026 --

Citius Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London PRNewswire 8:30 AM

-- November 4, 2026 --

Citius Oncology's Positive Quality of Life Data for LYMPHIR (denileukin diftitox-cxdl) in Relapsed or Refractory Cutaneous T-Cell Lymphoma Presented at Premier Global CLTG Congress in Europe PRNewswire 1:46 PM

-- October 26, 2026 --

Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026 PRNewswire 1:00 PM

-- October 12, 2026 --

Citius Pharmaceuticals to Participate in October 2026 Investor Conferences PRNewswire 8:30 AM

-- September 3, 2026 --

Citius Pharmaceuticals to Participate in September 2026 Investor Conferences PRNewswire 8:30 AM

-- August 14, 2026 --

Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update PRNewswire 4:30 PM

Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update PRNewswire 4:30 PM

-- August 12, 2026 --

Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri PRNewswire 8:01 AM

-- August 5, 2026 --

Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment PRNewswire 9:17 AM

-- July 21, 2026 --

Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption PRNewswire 9:17 AM

Market Data Delayed 15 Minutes